OBJECTIVES::  Global guidelines on T2DM treatment emphasize the importance of controlling glycosylated hemoglobin (HbA1c), blood pressure (BP), and body mass index (BMI) to mitigate cardiometabolic morbidity and mortality. Although individual measures have their clinical use, there is currently a trend towards applying CQM to assess quality of care. Empirical evidence shows that not meeting CQM is associated with a higher burden on the healthcare systems; to date, there is a lack of Latin American evidence on CQM. This study aimed to address this question by estimating the attainment of CQM in Brazilians with T2DM in RWD. METHODS::  Data came from the National Health and Wellness Survey (NHWS) Brazil fielded in 2011, 2013 and 2015. CQM were selected based on the literature and advice from clinical experts: CQM#1 (HbA1c<8%+BP<140/90mmHg+BMI 18.5-29.9kg/m), CQM#2 (HbA1c<7%+BP<140/90mmHg+BMI 18.5 to <29.9kg/m), CQM#3 (HbA1c<7%+BP<130/80mmHg+BMI 18.5 to <24.9kg/m) and CQM#4 (HbA1c<6.5%+ BP<130/80 mmHg+BMI 18.5 to <24.9 kg/m). Descriptive analysis was performed. RESULTS::  Among 1,709 respondents with T2DM, 225 (13.1%) reported values for each of the three CQM components. In this sub-sample, respondents had a mean age of 52.40 years (±12.26) and most were males (61.8%), of white ethnicity (68.4%), married/living with partner (64%), with private healthcare insurance (74.2%), and a college degree (54.7%). Among the 225 reporting CQM, only 29.3% (n=66) met CQM#1; 23.6% met CQM#2; 3.6% met CQM#3, and 3.1% met CQM#4. CONCLUSIONS::  In this study, less than a third of patients reporting CQM values attained the least stringent parameters. These results corroborate national publications reporting the poor level of control in Brazilian patients with T2DM and demonstrate opportunities to improve overall knowledge and achieve better diabetes-related outcomes. Further work should quantify the clinical and economic burden when diabetes-related CQM measures are unmet.